• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [916 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2017 Canary Health Service [Early detection of hepatocarcinoma in patients at risk]
2017 NIHR Health Technology Assessment programme Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project
2017 NIHR Health Services and Delivery Research programme Incentives in Diabetic Eye Assessment by Screening (IDEAS) trial: a three-armed randomised controlled trial of financial incentives
2017 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for hepatitis C virus: a systematic review
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Parent information on newborn screening using pulse oximetry; addendum to commission S13-01]
2016 NIHR Health Technology Assessment programme A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo Danish Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Newborn screening for tyrosinaemia type 1 using tandem mass spectrometry]
2016 HAYES, Inc. Epi proColon (Epigenomics Inc.)
2016 NIHR Health Technology Assessment programme Enhanced invitation methods and uptake of health checks in primary care: randomised controlled trial and cohort study using electronic health records
2016 NIHR Health Technology Assessment programme A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Information for health insurance fund members on ultrasound screening for abdominal aortic aneurysms: addendum to commission S13-04]
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for asymptomatic bacteriuria within the framework of the German maternity guidelines, under special consideration of test methods - Addendum to Commission S13-02]
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Invitation and decision aid for bowel cancer screening]
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Newborn screening for severe combined immunodeficiency (SCID screening)]
2016 Health Sciences Institute in Aragon (IACS) Effectiveness, security and economic evaluation of existing alternatives for monitoring growth and pubertal development
2016 Health Sciences Institute in Aragon (IACS) Effectiveness, safety and economic evaluation of existing alternatives for the early detection of childhood hearing impairment
2016 Health Sciences Institute in Aragon (IACS) Effectiveness, safety and economic evaluation of existing alternatives for the early detection of visual impairment in the paediatric population.
2016 NIHR Health Technology Assessment programme The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation
2016 Institute of Health Economics (IHE) Newborn blood spot screening for galactosemia, tyrosiemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease and severe combined immunodeficiency
2016 NIHR Health Technology Assessment programme A programme of studies including assessment of diagnostic accuracy of school hearing screening tests and a cost-effectiveness model of school entry hearing screening programmes
2016 Health Sciences Institute in Aragon (IACS) Effectiveness, security and economic evaluation of the screening for cryptorchidism
2016 NIHR Health Technology Assessment programme The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer
2016 NIHR Health Technology Assessment programme An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness
2016 Basque Office for Health Technology Assessment (OSTEBA) [Impact of the implementation of a population-based cervical cancer screening program based on European recommendations (test/interval) with regard to the current situation]
2016 NIHR Health Technology Assessment programme A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC)
2015 Health Council of the Netherlands Gezondheidsraad (GR) Neonatal screening: new recommendations
2015 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: study of faecal tests within the population based screening programme for colorectal cancer
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Assessment on nucleic acid amplification techniques (NAT) for human immunodeficiency, hepatitis C and hepatitis B virus screening in blood banks]
2015 NIHR Health Technology Assessment programme The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone
2015 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: Beta-kethiolase deficiency (BKT); 3-Hydroxy-3-methyl glutaric aciduria (HMG)]
2015 NIHR Health Technology Assessment programme A study of cellular counting to determine minimum thresholds for adequacy for liquid-based cervical cytology using a survey and counting protocol
2015 NIHR Health Technology Assessment programme Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials)
2015 NIHR Health Technology Assessment programme Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening
2015 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Economic evaluation of different strategies for screening for Chagas' disease in Spain]
2015 Health Quality Ontario (HQO) Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an evidence-based analysis
2015 Health Quality Ontario (HQO) Harms of Prostate-Specific Antigen (PSA) screening in prostate cancer: a rapid review
2015 Health Quality Ontario (HQO) Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an economic analysis
2015 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for asymptomatic bacteriuria within the framework of the German maternity guidelines, under special consideration of test methods]
2015 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Newborn screening for critical congenital heart disease using pulse oximetry]
2015 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part III: carnitine uptake deficiency (CUD); short-chain acyl-CoA dehydrogenase deficiency (SCADD); very long-chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2015 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Invitation and fact sheet for breast cancer Screening - Rapid report]
2015 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound screening for abdominal aortic aneurysms]
2015 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for visual impairment in children younger than 6 years - rapid report]
2015 Belgian Health Care Knowledge Centre (KCE) Cardiovascular pre-participation screening in young athletes
2015 NIHR Health Technology Assessment programme Screening for psychological and mental health difficulties in young people who offend: a systematic review and decision model
2015 NIHR Health Services and Delivery Research programme Translation into British Sign Language and validation of the Strengths and Difficulties Questionnaire
2015 Canary Health Service [Cost-effectiveness of neonatal screening for 3-hydroxy-3-methylglutaric aciduria (HMG)]
2015 Belgian Health Care Knowledge Centre (KCE) What are the recommended clinical assessment and screening tests during pregnancy?
2014 Health Council of the Netherlands Gezondheidsraad (GR) Fitness to drive requirements: some recommendations
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Vancomycin-resistant enterococci isolation and screening strategies: clinical evidence and cost-effectiveness
2014 Adelaide Health Technology Assessment (AHTA) Bone mineral density analyses using dual energy x-ray absorptiometry (DXA) for women in their 50th year
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism. Part II: Methylmalonic acidemia, Propionic acidemia, Tyrosinemia type I]
2014 HAYES, Inc. Cologuard
2014 HAYES, Inc. Screening for Lynch syndrome
2014 Basque Office for Health Technology Assessment (OSTEBA) [Diagnosis of gestational diabetes mellitus: evaluation of the new IADPSG criteria]
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Frequency of rescreening of patients negative for antibiotic resistant organisms: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Universal screening for antibiotic-resistant organisms in long-term care facilities: clinical effectiveness and guidelines
2014 NIHR Horizon Scanning Centre (NIHR HSC) SoftVue™ system for diagnostic breast imaging
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) HPV OncoTect E6, E7 mRNA assay to guide colposcopy referral in cervical cancer screening
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Neonatal screening for lysosomal storage disorders
2014 Agency for Healthcare Research and Quality (AHRQ) Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force
2014 Agency for Healthcare Research and Quality (AHRQ) Screening for vitamin D deficiency: systematic review for the U.S. Preventive Services Task Force Recommendation
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Routine ordering of primary pathology examinations in Canada
2014 Agency for Healthcare Research and Quality (AHRQ) Screening for high blood pressure in adults: a systematic evidence review for the U.S. Preventive Services Task Force
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Mass thermography screening for infection and prevention: a review of the clinical effectiveness
2014 National Evidence-based Healthcare Collaborating Agency (NECA) [The mortality rate and medical costs identified by a national health examination analysis]
2014 National Evidence-based Healthcare Collaborating Agency (NECA) [Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in South Korea]
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Infection prevention and control procedures for carbapenemase-producing Enterobacteriaceae: clinical effectiveness and guidelines
2014 NIHR Horizon Scanning Centre (NIHR HSC) BreathLink™ for breast cancer screening
2014 Belgian Health Care Knowledge Centre (KCE) A decision aid for an informed choice when patient asks for PSA screening
2014 Medical Services Advisory Committee (MSAC) National Cervical Screening Program renewal
2014 Belgian Health Care Knowledge Centre (KCE) Informed choice on breast cancer screening: messages to support informed decision
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Neonatal screening for biotinidase deficiency]
2014 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Development of composite indicators to measure the quality of prevention and chronic management activities for gynecological cancer screening in primary care]
2014 Agency for Healthcare Research and Quality (AHRQ) Screening for gonorrhea and chlamydia: systematic review to update the U.S. Preventive Services Task Force Recommendations
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of an HPV test in primary screening for cervical cancer - Rapid report]
2014 NIHR Horizon Scanning Centre (NIHR HSC) Cologuard® for colorectal cancer screening
2014 NIHR Horizon Scanning Centre (NIHR HSC) Pediatric Vision Scanner for the detection of eye conditions in children
2014 Agency for Healthcare Research and Quality (AHRQ) Screening for hepatitis B virus infection in nonpregnant adolescents and adults: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation
2014 Blue Cross Blue Shield Association (BCBS) Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis
2014 Blue Cross Blue Shield Association (BCBS) Special report: screening asymptomatic women with dense breasts and normal mammograms for breast cancer
2014 NIHR Health Technology Assessment programme A modelled analysis using data from the ARTISTIC trial of the potential effectiveness and cost-effectiveness of HPV testing in cervical cancer screening
2014 Health Council of the Netherlands Gezondheidsraad (GR) Population screening for breast cancer: expectations and developments
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Neonatal screening for classic galactosemia. Systematic review]
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Newborn screening for congenital adrenal hyperplasia. Systematic Review]
2014 HAYES, Inc. Magnetic resonance imaging (MRI) for surveillance for breast cancer recurrence following mastectomy and breast reconstruction
2014 Adelaide Health Technology Assessment (AHTA) Molecular testing for prostate cancer prognosis
2014 Agency for Healthcare Research and Quality (AHRQ) Primary care screening for abdominal aortic aneurysm: a systematic evidence review for the U.S. preventive services task force
2014 HAYES, Inc. Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening
2014 HAYES, Inc. Digital breast tomosynthesis for breast cancer diagnosis and screening
2014 Canary Health Service [Cost-effectiveness of neonatal screening for very long chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2014 Canary Health Service [Cost-effectiveness of neonatal screening for primary carnitine deficiency]
2014 HAYES, Inc. High-resolution anoscopy for the evaluation of anal lesions
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Population-based colorectal cancer screening: guidelines
2013 Canary Health Service [Cost-effectiveness of newborn screening for sickle cell anemia]
2013 NIHR Health Technology Assessment programme Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Newborn screening for cystic fibrosis. Efficacy/ effectiveness and implementation protocols]
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Neonatal screening of sickle cell anemia]
2013 NIHR Health Technology Assessment programme Screening for type 2 diabetes: a short report for the National Screening Committee
2013 Health Quality Ontario (HQO) Screening and management of depression for adults with chronic diseases: an evidence-based analysis